Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: Predictors and impact on subsequent oncological outcomes from a national multicenter study

World Journal of Urology

Volumn 31, Issue 1, 2013, Pages 61-68

  Xylinas, Evanguelos ^a   Colin, Pierre ^b   Audenet, François ^c   Phe, Véronique ^c   Cormier, Luc ^d   Cussenot, Olivier ^e   Houlgatte, Alain ^f   Karsenty, Gilles ^g   Bruyère, Franck ^h   Polguer, Thomas ⁱ   Ruffion, Alain ^j   Valeri, Antoine ^k   Rozet, François ^l   Long, Jean Alexandre ^m   Zerbib, Marc ^a   Rouprêt, Morgan ^c  

^a Institut Cochin   (France)

^b UNIV LILLE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITÉ DE BOURGOGNE   (France)

^e HÔPITAL TENON   (France)

^f University of Paris Descartes   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^h UNIVERSITÉ DE TOURS   (France)

ⁱ UNIVERSITÉ CLERMONT AUVERGNE   (France)

^j UNIVERSITÉ LYON 1   (France)

^k UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^l INSTITUT MUTUALISTE MONTSOURIS   (France)

^m UNIV GRENOBLE ALPES   (France)

more..

Author keywords

Bladder neoplasm; Radical nephroureterectomy; Recurrence; Renal pelvis; Survival; Ureter; Urothelial carcinoma

Indexed keywords

EID: 84873140268     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-012-0957-3     Document Type: Article

References (24)

1. Margulis V, Shariat SF, Matin SF et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115: 1224-1233.
2. Rouprêt M, Zigeuner R, Palou J et al (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 59: 584-594.
3. Raman JD, Ng CK, Boorjian SA, Vaughan ED Jr, Sosa RE, Scherr DS (2005) Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int 96: 1031-1035.
4. Zigeuner RE, Hutterer G, Chromecki T, Rehak P, Langner C (2006) Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int 98: 1181-1186.
5. Novara G, De Marco V, Dalpiaz O et al (2008) Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. BJU Int 101: 1368-1374.
6. Mullerad M, Russo P, Golijanin D et al (2004) Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol 172: 2177-2181.
7. Rabbani F, Perrotti M, Russo P, Herr HW (2001) Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance. J Clin Oncol 19: 94-100.
8. Wheat JC, Weizer AZ, Wolf JS, et al (2012) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol 30(3): 252-258.
9. Pieras E, Frontera G, Ruiz X et al (2010) Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 106: 1319-1323.
10. Otto W, Shariat SF, Fritsche HM et al (2011) Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. World J Urol 29: 487-494.
11. Xylinas E, Rink M, Cha EK, et al (2012) Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. http://dx. doi. org/10. 1016/j. eururo. 2012. 04. 052.
12. Greene FL, Balch CM, Fleming ID et al (2002) AJCC cancer staging handbook: TNM classification of malignant tumors, 6th edn. American Joint Committee on Cancer, Chicago, IL.
13. Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22: 1435-1448.
14. Ouzzane A, Colin P, Xylinas E et al (2011) Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Eur Urol 60: 1258-1265.
15. Chromecki TF, Cha EK, Fajkovic H et al (2012) The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 61: 245-253.
16. Novara G, Matsumoto K, Kassouf W et al (2010) Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 57: 1064-1071.
17. Rink M, Fajkovic H, Cha EK, et al (2012) Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61(4): 854-855.
18. Volkmer BG, Schnoeller T, Kuefer R, Gust K, Finter F, Hautmann RE (2009) Upper urinary tract recurrence after radical cystectomy for bladder cancer-who is at risk? J Urol 182: 2632-2637.
19. Xylinas E, Rink M, Margulis V et al (2012) Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. Eur Urol 61: 1069-1070.
20. Ariane MM, Colin P, Ouzzane A et al (2012) Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): results from a large French multicenter collaborative study. Ann Surg Oncol 19: 301-308.
21. Favaretto RL, Shariat SF, Chade DC et al (2010) Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? Eur Urol 58: 645-651.
22. Capitanio U, Shariat SF, Isbarn H et al (2009) Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol 56: 1-9.
23. Walton TJ, Novara G, Matsumoto K et al (2011) Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort. BJU Int 108: 406-412.
24. O'Brien T, Ray E, Singh R, Coker B, Beard R, British Association of Urological Surgeons Section of Oncology (2011) Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomized clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol 60: 703-710.